Literature DB >> 11853005

Disruption of oncogene/tumor suppressor networks during human carcinogenesis.

Karl Münger1.   

Abstract

Oncogenes were initially discovered as retrovirally transmitted tumor causing agents. The realization that such retroviral oncogenes constitute specifically altered versions of cellular genes-proto-oncogenes, was a landmark discovery that set the stage for the molecular and mechanistic era of cancer research. Moreover, the studies on oncogene functions have been instrumental in delineating many of the paradigms of cellular signal transduction. In contrast to the original studies in animals, oncogenic activation through retroviral transmission does not appear to be a major factor in human tumorigenesis. However, oncogenes are frequently activated by gain of function mutations or fusions with other genes, or they are aberrantly expressed due to amplification, increased promoter activity, or protein stabilization, and hence they play integral roles in the genesis of human tumors.

Entities:  

Mesh:

Year:  2002        PMID: 11853005     DOI: 10.1081/cnv-120000369

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  6 in total

1.  Enhanced cell survival of gastric cancer cells by a novel gene URG4.

Authors:  Jiugang Song; Huahong Xie; Zhaorui Lian; Guitao Yang; Rui Du; Yulei Du; Xue Zou; HaiFeng Jin; Juan Gao; Jie Liu; Daiming Fan
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

2.  The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma.

Authors:  X-W Wan; M Jiang; H-F Cao; Y-Q He; S-Q Liu; X-H Qiu; M-C Wu; H-Y Wang
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-07       Impact factor: 4.553

3.  The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma.

Authors:  Bozena Konopka; Aneta Janiec-Jankowska; Zygmunt Paszko; Marian Goluda
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-09       Impact factor: 4.553

4.  Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo.

Authors:  Scott J Balsitis; Julien Sage; Stefan Duensing; Karl Münger; Tyler Jacks; Paul F Lambert
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

5.  Alteration of gene expression profiles during mycoplasma-induced malignant cell transformation.

Authors:  Shimin Zhang; Shien Tsai; Shyh-Ching Lo
Journal:  BMC Cancer       Date:  2006-05-04       Impact factor: 4.430

6.  Evaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesions.

Authors:  Hong Xie; Ingrid Norman; Anders Hjerpe; Tomislav Vladic; Catharina Larsson; Weng-Onn Lui; Ellinor Östensson; Sonia Andersson
Journal:  Oncol Lett       Date:  2017-03-24       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.